Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ITI
13701
PUT
DELISTED
Iteris, Inc.
ITI
| $2.14K | ﹤0.01% |
+300
| New | +$1.79K |
2024 Q3
0 quarters
|
|
13702
PUT
Urban Edge Properties
UE
$2.48B
| $2.14K | ﹤0.01% |
100
-3,400
| -97% | -$68.4K |
2022 Q4
7 quarters
|
|
|
CMCM
13703
PUT
Cheetah Mobile
CMCM
$81.3M
| $2.13K | ﹤0.01% |
+500
| New | +$1.86K |
2024 Q3
0 quarters
|
|
|
BRACR
13704
DELISTED
Broad Capital Acquisition Corp Rights
BRACR
| $2.13K | ﹤0.01% |
17,740
-10,538
| -37% | -$1.72K |
2024 Q1
2 quarters
|
|
|
BHACW
13705
DELISTED
Focus Impact BH3 Acquisition Company Warrants
BHACW
| $2.13K | ﹤0.01% |
60,837
+20,404
| +50% | +$1.25K |
2023 Q2
5 quarters
|
|
13706
PUT
First Bancorp
FBP
$4.15B
| $2.12K | ﹤0.01% |
100
-200
| -67% | -$4.07K |
2024 Q2
1 quarter
|
|
13707
PUT
TRX Gold Corp
TRX
$390M
| $2.12K | ﹤0.01% |
+5,400
| New | +$2.17K |
2024 Q3
0 quarters
|
|
13708
PUT
CuriosityStream
CURI
$173M
| $2.1K | ﹤0.01% |
+1,100
| New | +$1.5K |
2024 Q3
0 quarters
|
|
|
BNIXR
13709
DELISTED
Bannix Acquisition Corp. Right
BNIXR
| $2.1K | ﹤0.01% |
29,120
-1,033
| -3% | -$113 |
2023 Q1
6 quarters
|
|
|
LGO
13710
CALL
Largo
LGO
$55M
| $2.09K | ﹤0.01% |
1,000
-2,000
| -67% | -$3.73K |
2022 Q1
10 quarters
|
|
13711
CALL
Mizuho Financial
MFG
$134B
| $2.09K | ﹤0.01% |
500
-16,400
| -97% | -$68.5K |
2022 Q3
8 quarters
|
|
13712
CALL
Retractable Technologies
RVP
$20.7M
| $2.08K | ﹤0.01% |
2,700
-1,300
| -33% | -$1.31K |
2022 Q3
8 quarters
|
|
|
MSPRZ
13713
DELISTED
MSP Recovery Inc Warrant
MSPRZ
| $2.07K | ﹤0.01% |
42,236
+162
| +0.4% | +$7 |
2024 Q2
1 quarter
|
|
|
EHI.RT
13714
DELISTED
Western Asset Global High Income Fund Inc. Rights (expiring October 8, 2024)
EHI.RT
| $2.01K | ﹤0.01% |
+182,726
| New | +$4.2K |
2024 Q3
0 quarters
|
|
13715
CALL
Trevi Therapeutics
TRVI
$1.95B
| $2K | ﹤0.01% |
+600
| New | +$1.78K |
2024 Q3
0 quarters
|
|
13716
PUT
Apyx Medical
APYX
$109M
| $1.98K | ﹤0.01% |
1,600
+600
| +60% | +$758 |
2022 Q4
7 quarters
|
|
13717
Outset Medical
OM
$76.1M
| $1.98K | ﹤0.01% |
195
-19,372
| -99% | -$576K |
2020 Q3
16 quarters
|
|
13718
PUT
Cue Biopharma
CUE
$176M
| $1.97K | ﹤0.01% |
87
-283
| -76% | -$6.13K |
2022 Q4
7 quarters
|
|
13719
PUT
AGF US Market Neutral Anti-Beta Fund
BTAL
$310M
| $1.96K | ﹤0.01% |
+100
| New | +$1.99K |
2024 Q3
0 quarters
|
|
|
NKGNW
13720
DELISTED
NKGen Biotech, Inc. Warrants
NKGNW
| $1.95K | ﹤0.01% |
27,626
+1,100
| +4% | +$98 |
2024 Q1
2 quarters
|
|
13721
PUT
Quadratic Interest Rate Volatility and Inflation Hedge ETF
IVOL
$243M
| $1.93K | ﹤0.01% |
+100
| New | +$1.92K |
2024 Q3
0 quarters
|
|
13722
PUT
QuinStreet
QNST
$857M
| $1.91K | ﹤0.01% |
100
-2,600
| -96% | -$47.4K |
2022 Q4
7 quarters
|
|
13723
CALL
Harvard Bioscience
HBIO
$38.6M
| $1.88K | ﹤0.01% |
70
-50
| -42% | -$1.47K |
2024 Q1
2 quarters
|
|
|
JBIO
13724
PUT
Jade Biosciences
JBIO
$894M
| $1.88K | ﹤0.01% |
26
-851
| -97% | -$54.9K |
2024 Q2
1 quarter
|
|
|
SLAI
13725
PUT
DELISTED
SOLAI Ltd ADS
SLAI
| $1.88K | ﹤0.01% |
114
-300
| -72% | -$5.28K |
2023 Q1
6 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.